Search

everythinglearnresearchcommunity

for

Search:↓

Encapsulating hair loss drugs in cyclodextrins improves their solubility and reduces scalp irritation.

Guaraná extract effectively reduces oiliness in skin and hair without harming skin health.

Low-Level Light Therapy improves quality of life more for women than men with hair loss.

L-PGDS has specific binding sites for its functions and could help in drug delivery system design.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

Proretinal nanoparticles are a safe and effective way to deliver retinal to the skin.

The summit aimed to speed up finding treatments for alopecia areata.

Losing weight and eating better are key to managing metabolic syndrome and its related conditions.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

Obesity negatively affects the endometrium, leading to higher miscarriage risk and impaired cell function.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Silver nanoparticles can significantly promote hair growth.

Removing part of the vitamin D receptor stops vitamin D from working properly.

Zinc is effective for treating various skin conditions, including warts and acne.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Asia has made significant progress in tissue engineering and regenerative medicine, but wider clinical use requires more development.

Finasteride may cause slight depression and anxiety.

Higher free testosterone levels in men are linked to a stronger immune response, not weaker.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Women with excess body hair feel psychological distress influenced by societal beauty standards, but distress isn't directly linked to the amount of hair.

LED therapy is safe and shows potential for treating skin conditions and promoting hair growth, but more research is needed.

Both mouse and rat models are effective for testing alopecia areata treatments.

Photothermal hydrogels are promising for infection control and tissue repair, and combining them with other treatments could improve results and lower costs.

Flutamide reduces hair growth better but has more side effects.

The study found that bioengineered hair follicles work when using cells from the same species but have issues when combining human and mouse cells.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Fluconazole is an effective antifungal medication with potential side effects and lacks official analytical methods for its determination.

A blood pressure drug, diltiazem, may also help treat influenza.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.